| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LAVA Therapeutics NV | Chief Executive Officer, Director | Common Shares | 0 | $0 | $1.63 | 13 Nov 2025 | Direct |
| LAVA Therapeutics NV | Chief Executive Officer, Director | Share Options (Right to Buy) | 0 | 13 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LVTX | LAVA Therapeutics NV | 13 Nov 2025 | 2 | $0 | 4 | Chief Executive Officer, Director | 17 Nov 2025, 16:30 |
| LVTX | LAVA Therapeutics NV | 13 Feb 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 18 Feb 2025, 20:15 |
| LVTX | LAVA Therapeutics NV | 01 Jan 2025 | 0 | $0 | 3 | Chief Executive Officer, Director | 02 Jan 2025, 09:19 |